Milind Velhal , Shriya Pande , Ritesh Fule , Nitin Dumore , Md Ali Mujtaba , Ali F. Almutairy , Ameeduzzafar Zafar , Mohammad Khalid
{"title":"利用超临界流体技术制备视黄醇聚乳酸-羟基乙酸纳米颗粒:基于析因设计的优化、理化表征和细胞活力评估","authors":"Milind Velhal , Shriya Pande , Ritesh Fule , Nitin Dumore , Md Ali Mujtaba , Ali F. Almutairy , Ameeduzzafar Zafar , Mohammad Khalid","doi":"10.1016/j.cherd.2025.09.033","DOIUrl":null,"url":null,"abstract":"<div><div>Retinol acetate (RA) has potential antineoplastic and chemo-preventive activities. However, RA is highly hydrophobic, which decreases its bioavailability and limits its therapeutic potential. Therefore, this study aimed to develop and characterize poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) using supercritical fluid technology (SFT). Additionally, the therapeutic effectiveness of RA-loaded PLGA-NPs was evaluated using cytotoxicity assay. In the present investigation, we have explored novel, green technology for preparing PLGA-NPs, which is the modified rapid expansion of supercritical solution (RESS) with mixing and sonication. Preoptimization feasibility studies were taken into consideration when choosing dependent and independent factors. 2<sup>3</sup> full factorial design was applied to quantify the effect of dependent factors on independent factors. The optimized RA-loaded PLGA-NPs formulation was characterized by various parameters. The average particle size, polydispersity index, and zeta potential of optimized PLGA-NPs were 100.8 ± 10 nm, 0.412 ± 0.08, and −17.6 mV, respectively. The drug content was observed to be 82 ± 5 % and % entrapment efficiency was found to be 99.6 ± 0.32 %. The XRD and DSC of NPs showed that the drug is in a non-crystalline state. FTIR spectroscopy confirmed the effective incorporation of RA into the PLGA-NPs. SEM and TEM studies exhibit uniform-shaped particles of 70–100 nm size. The release of the drug from RA-PLGA nanoparticles was regulated by the initial diffusion of RA and later by the degradation of the biodegradable polymer. MTT assay revealed that the RA-loaded PLGA-NPs were superior in arresting cell growth as compared to free RA. In summary, RA-encapsulated PLGA-NPs, prepared by the SFT, have great potential as a drug delivery system for clinical applications in anti-cancer treatment.</div></div>","PeriodicalId":10019,"journal":{"name":"Chemical Engineering Research & Design","volume":"222 ","pages":"Pages 500-515"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of poly (lactic-Co-glycolic acid) nanoparticles of retinol using supercritical fluid technology: Factorial design-based optimization, physicochemical characterization and cell viability assessment\",\"authors\":\"Milind Velhal , Shriya Pande , Ritesh Fule , Nitin Dumore , Md Ali Mujtaba , Ali F. Almutairy , Ameeduzzafar Zafar , Mohammad Khalid\",\"doi\":\"10.1016/j.cherd.2025.09.033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Retinol acetate (RA) has potential antineoplastic and chemo-preventive activities. However, RA is highly hydrophobic, which decreases its bioavailability and limits its therapeutic potential. Therefore, this study aimed to develop and characterize poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) using supercritical fluid technology (SFT). Additionally, the therapeutic effectiveness of RA-loaded PLGA-NPs was evaluated using cytotoxicity assay. In the present investigation, we have explored novel, green technology for preparing PLGA-NPs, which is the modified rapid expansion of supercritical solution (RESS) with mixing and sonication. Preoptimization feasibility studies were taken into consideration when choosing dependent and independent factors. 2<sup>3</sup> full factorial design was applied to quantify the effect of dependent factors on independent factors. The optimized RA-loaded PLGA-NPs formulation was characterized by various parameters. The average particle size, polydispersity index, and zeta potential of optimized PLGA-NPs were 100.8 ± 10 nm, 0.412 ± 0.08, and −17.6 mV, respectively. The drug content was observed to be 82 ± 5 % and % entrapment efficiency was found to be 99.6 ± 0.32 %. The XRD and DSC of NPs showed that the drug is in a non-crystalline state. FTIR spectroscopy confirmed the effective incorporation of RA into the PLGA-NPs. SEM and TEM studies exhibit uniform-shaped particles of 70–100 nm size. The release of the drug from RA-PLGA nanoparticles was regulated by the initial diffusion of RA and later by the degradation of the biodegradable polymer. MTT assay revealed that the RA-loaded PLGA-NPs were superior in arresting cell growth as compared to free RA. In summary, RA-encapsulated PLGA-NPs, prepared by the SFT, have great potential as a drug delivery system for clinical applications in anti-cancer treatment.</div></div>\",\"PeriodicalId\":10019,\"journal\":{\"name\":\"Chemical Engineering Research & Design\",\"volume\":\"222 \",\"pages\":\"Pages 500-515\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chemical Engineering Research & Design\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0263876225005106\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, CHEMICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemical Engineering Research & Design","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0263876225005106","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, CHEMICAL","Score":null,"Total":0}
Development of poly (lactic-Co-glycolic acid) nanoparticles of retinol using supercritical fluid technology: Factorial design-based optimization, physicochemical characterization and cell viability assessment
Retinol acetate (RA) has potential antineoplastic and chemo-preventive activities. However, RA is highly hydrophobic, which decreases its bioavailability and limits its therapeutic potential. Therefore, this study aimed to develop and characterize poly lactic-co-glycolic acid (PLGA) nanoparticles (NPs) using supercritical fluid technology (SFT). Additionally, the therapeutic effectiveness of RA-loaded PLGA-NPs was evaluated using cytotoxicity assay. In the present investigation, we have explored novel, green technology for preparing PLGA-NPs, which is the modified rapid expansion of supercritical solution (RESS) with mixing and sonication. Preoptimization feasibility studies were taken into consideration when choosing dependent and independent factors. 23 full factorial design was applied to quantify the effect of dependent factors on independent factors. The optimized RA-loaded PLGA-NPs formulation was characterized by various parameters. The average particle size, polydispersity index, and zeta potential of optimized PLGA-NPs were 100.8 ± 10 nm, 0.412 ± 0.08, and −17.6 mV, respectively. The drug content was observed to be 82 ± 5 % and % entrapment efficiency was found to be 99.6 ± 0.32 %. The XRD and DSC of NPs showed that the drug is in a non-crystalline state. FTIR spectroscopy confirmed the effective incorporation of RA into the PLGA-NPs. SEM and TEM studies exhibit uniform-shaped particles of 70–100 nm size. The release of the drug from RA-PLGA nanoparticles was regulated by the initial diffusion of RA and later by the degradation of the biodegradable polymer. MTT assay revealed that the RA-loaded PLGA-NPs were superior in arresting cell growth as compared to free RA. In summary, RA-encapsulated PLGA-NPs, prepared by the SFT, have great potential as a drug delivery system for clinical applications in anti-cancer treatment.
期刊介绍:
ChERD aims to be the principal international journal for publication of high quality, original papers in chemical engineering.
Papers showing how research results can be used in chemical engineering design, and accounts of experimental or theoretical research work bringing new perspectives to established principles, highlighting unsolved problems or indicating directions for future research, are particularly welcome. Contributions that deal with new developments in plant or processes and that can be given quantitative expression are encouraged. The journal is especially interested in papers that extend the boundaries of traditional chemical engineering.